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Abstract 17 
One hundred and fifty four pre-weaning calves were followed between May and October 2015. 18 
Calves were fitted with continuous monitoring temperature probes (TempVerified FeverTag ®, 19 
Amarillo, Texas, USA), programmed so a flashing LED light was triggered following 6 hours of a 20 
sustained ear canal temperature of ≥39.7oC. A total of 83 calves (61.9%) developed undifferentiated 21 
pyrexia, with a presumptive diagnosis of pneumonia through exclusion of other calf diseases. Once 22 
pyrexia was detected, calves were randomly allocated to two treatment groups. Calves in Group 1 23 
(NSAID) received 2mg/kg flunixin meglumine (Allevinix, Merial) for three consecutive days, and 24 
Group 2 (antimicrobial) received 6mg/kg gamithromycin (Zactran, Merial). If pyrexia persisted 72 25 
hours after the initial treatment, calves were given further treatment (Group 1 received 26 
antimicrobial and Group 2 received NSAID). Group 1 (NSAID) were five times more likely (p=0.002) to 27 
require  a second treatment (the antimicrobial) after 72 hours to resolve the pyrexia compared to 28 
the need to give Group 2 (antimicrobial) calves a second treatment (the NSAID). This demonstrates 29 
the importance of on-going monitoring and follow-up of calves with respiratory disease. However, of 30 
calves with pyrexia in Group 1 (NSAID), 25.7% showed resolution following NSAID treatment only 31 
with no detrimental effect on the development of repeated pyrexia or daily live weight gain. This 32 
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suggests that NSAID alone may be a useful first line treatment giving a total of 30.1% reduction of 33 
antimicrobial usage between the groups in this sample, provided adequate attention is given to 34 
ongoing monitoring in order to identify those cases that require additional antimicrobial treatment. 35 
 36 
Introduction 37 
Growth and development of healthy calves through the pre-weaning period is important both for 38 
ensuring longevity of the animals produced, and to enable rearing costs to be maintained at an 39 
economically viable price. A single case of pneumonia is estimated to cost approximately £43 per 40 
dairy calf affected, with approximately 47% of dairy calves and 51% of beef animals in the UK being 41 
affected (Esslemont and others, 1998). The main economic costs are due to decreased growth rates 42 
(Wittum and others, 1996), the cost of drug treatments (Schneider and others, 2009) and mortality 43 
which can range from 0.18% to 3.9% (Elliott and others, 2014).  44 
While early detection of calf pneumonia may improve treatment success and reduce infectious 45 
spread, the subtle signs associated with early disease (loss of appetite, depression or raised 46 
respiratory rate) are difficult to detect and often missed in the farm situation. Nasal discharge 47 
typically appears a median of 19 hours after pyrexia develops, followed by a cough at a median of 65 48 
hours after pyrexia develops (Timsit and others, 2011). However many authors advocate the 49 
detection of an undifferentiated pyrexia as an indication for the initiation of treatment (Apley, 50 
2006), with the aim being to introduce therapy before the disease has progressed enough to cause 51 
clinical signs.  52 
 53 
The time consuming nature of manual restraint and examination of rectal temperatures in calves 54 
invariably deters regular monitoring for pyrexia in groups of calves. Remote detection of pyrexia 55 
through the use of technology is a growing field, with infrared thermography scans and reticulo-56 
rumen temperature boluses having been trialled, but with limited application in the field due to 57 
costs (Timsit and others, 2011). Recent development and advances in technology means continuous 58 
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real-time monitoring in calves has become more affordable through a novel ear-canal sensor 59 
(TempVerified FeverTags ®, Amarillo, Texas, USA). Each tag is a self-contained unit, made up of a 60 
temperature probe that is inserted deep into the external ear canal, and a small circuit board with 61 
an LED light which is secured in the pinna using a standard ear tag applicator. 62 
 63 
With regard to the treatment of pneumonia, NSAIDs have demonstrated efficacy in treatment of 64 
pneumonia when used in conjunction with antimicrobials due their effects on reduction of lung 65 
consolidation (Lockwood, et al., 2003). However, no studies have assessed the use of NSAIDs as a 66 
stand-alone treatment where early detection for calf pneumonia is undertaken. Therefore, a 67 
rationale for such a course of action could be that if detection is early enough in the course of the 68 
disease and the pneumonia of ‘simple’ viral aetiology, then the use of antimicrobials could be 69 
considered unnecessary. 70 
 71 
This study aimed to use a randomised trial to directly compare the efficacy of NSAID therapy with 72 
antimicrobial therapy for the treatment of undifferentiated pyrexia, with the pyrexia defined as 73 
sustained ear canal temperature of 39.7oC detected by TempVerified FeverTags. We hypothesise 74 
that the use of an early NSAID treatment will reduce the requirement for antimicrobial usage as 75 
determined by resolution of the pyrexia.  76 
 77 
Materials and Methods 78 
A randomised positive control study design was used to compare the level of antimicrobial usage 79 
and growth rates between calves that were treated with an initial course of NSAID and an initial 80 
course of antimicrobial. The trial protocol was reviewed and approved by the Royal Veterinary 81 
College’s Ethical Review Committee (URN 2015 1317) and was granted a VMD Animal Test Certificate 82 
(ATC-S-057) before commencement of the study. A power calculation indicated that treatment 83 
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group sizes of 48 would detect a 30% difference in the proportion of calves requiring further 84 
treatment after 72 hours. Power was set at β=0.8, significance at p≤0.05. 85 
 86 
Animals 87 
Two Holstein dairy herds were recruited in the South-West of England. Both herds were closed, with 88 
vaccination for BVD, IBR and Leptospirosis in use in the adult herd, and no vaccination in the calves. 89 
Calves were kept in large barns with a shared air space using natural ventilation, a range of ages 90 
from 0-16 weeks old and an all year round calving pattern. All calves were Holstein-Friesian, with 91 
both male and female calves recruited into the study. Both farms fed the same milk replacer (20% 92 
whey protein, 18.5% fat, 8.3% ash). Further information on the farm management is detailed in 93 
Table 1. 94 
 95 
Table 1: Description of farm and management systems on Farm 1 and Farm 2. 96 
 Farm 1 Farm 2 
Adult Herd Size 300 200 
Colostrum fed Total 6L within 12 hours Total 6L within 12 hours 
Milk replacer fed 900g/day from birth, fed at 150g/L 600g/day from birth to 3 weeks, then 
800g/day until weaning, fed at 125g/L 
Calf group sizes 5 30 
Milk feeding method Group teat bucket Automatic milk machine 
Additional feed Ad-lib concentrates, straw bedding Ad-lib concentrates, straw in racks 
and bedding 
Weaning age 10 weeks 10 weeks 
 97 
 98 
5 
 
Calves were allocated to treatment groups by random number generation conducted by SAM. Calves 99 
were included if they developed pyrexia related to respiratory disease between the ages of 0 to10 100 
weeks (pre-weaning calves).  The origin of the pyrexia was determined to be due to respiratory 101 
infection by exclusion of other common calf diseases (navel ill, joint ill, diarrhoea) through a 102 
structured protocol for physical examination carried out by the farmer. Calves were removed from 103 
the study if they developed other diseases that required NSAID or antimicrobial therapy such as 104 
navel ill and joint ill. Calves that developed diarrhoea and were treated with oral electrolyte fluids 105 
(Lifeaid, Norbrook) were retained in the study unless they received additional  NSAID or 106 
antimicrobial treatment (given at the farmer’s discretion).  107 
 108 
Pyrexia detection 109 
External ear canal temperature was measured as a proxy for core temperature every 15 minutes 110 
using a temperature probe that was inserted 5 cm deep into the external ear canal, and a small 111 
circuit board with an LED light which was secured in the pinna using a standard ear tag applicator 112 
(TempVerified FeverTag ®, Amarillo, Texas, USA) (Figure 1). When the device detected pyrexia (ear 113 
canal temperature ≥39.7oC) for a sustained period of 6 hours, an LED light would flash for 6 hours to 114 
draw attention to the animal. The device would then enter a monitoring phase with the temperature 115 
taken every 15 minutes, and flashing would resume immediately if pyrexia was detected again. Only 116 
one other study (McCorkell and others, 2014) has used FeverTags for identificatrion of repiratory 117 
disease related pyrexia, although an earlier version of the tag was used which did not have the 6 118 
hour monitoring phase of the TempVerified model. 119 
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 120 
Figure 1: The TempVerified FeverTag consists of a temperature probe and casing to house the circuit 121 
board, battery and LED indicator light. 122 
 123 
Treatment protocol 124 
Calves were enrolled into one of two treatment groups: Group 1 (NSAID) received Flunixin 125 
meglumine (Allevinix, Merial) at 2 mg/kg via intramuscular injection daily for 3 consecutive days 126 
starting when the flashing tag was observed. If clinical signs of acute pneumonia developed after 24 127 
hours (spontaneous coughing, severe nasal or ocular discharge, tachypnoea), or if the FeverTag was 128 
still flashing after 72 hours (indicating continued pyrexia), calves were given Gamithromycin 129 
(Zactran, Merial) at 6 mg/kg via a single subcutaneous injection. Group 2 (antimicrobial) received 130 
Gamithromycin (Zactran, Merial) at 6 mg/kg via a single subcutaneous injection starting when the 131 
flashing tag was observed. If clinical signs of acute pneumonia developed after 24 hours, or the 132 
FeverTag was still flashing after 72 hours, then calves were given a NSAID treatment with Flunixin 133 
meglumine (Allevinix , Merial) at 2 mg/kg via intramuscular injection daily for 3 consecutive days.  134 
Pyrexia for up to 72 hours following treatment without clinical disease was deemed tolerable as this 135 
allowed sufficient time for full therapeutic action and to prevent unnecessary secondary treatments. 136 
A repeat case of pyrexia was defined as a temperature of ≥39.7oC for 6 hours which was detected at 137 
least 10 days following the last treatment given for the initial case of pyrexia. A 10 day duration was 138 
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chosen as this is the licensed duration of action of Zactran in calves. Repeat cases of pyrexia were 139 
treated using the same protocol as initial cases, and recorded as a repeat case of pyrexia within the 140 
statistics. 141 
 Calves were weighed at birth and weaning using a calf weigh scale (mechanical calf weighing crate, 142 
Bateman, UK).  Further data on calf mortality and treatments given to the study animals was 143 
collected up to 6 months of age from the farm records.  144 
 145 
Statistical analysis 146 
Data was analysed using SPSS (SPSS version 21, Lead technologies 2012). Associations between the 147 
efficacy of each treatment group, the sex, the farm and the occurrence of diarrhoea was tested 148 
using binary logistic regression. Associations between the treatment group and daily live weight gain 149 
was tested using analysis of variance (ANOVA). Associations between the requirement for a second 150 
treatment (continuation of pyrexia 72 hours after the initial drug treatment) and sex, treatment 151 
group, farm and development of diarrhoea in the first two weeks of life was tested using binary 152 
logistic regression for calves that experienced an episode of pyrexia. Kaplan Meier survival analysis 153 
was used to assess the age at which respiratory disease related pyrexia was first detected.  154 
 155 
 156 
Results 157 
A total of 154 calves were enrolled into the study between May and October 2015 (Table 2) with 83 158 
developing pyrexia assumed to be related to respiratory disease. Eight calves were excluded due to 159 
pyrexia detected by the FeverTag being caused by navel ill, and 12 calves were excluded due to 160 
development of diarrhoea which required antimicrobial or NSAID treatment, although no pyrexia 161 
was detected by the FeverTags in these calves.  162 
 163 
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Table 2: Total number of calves recruited into the trial and their division into the different treatment 164 
groups once pyrexia had developed 165 
 Farm 1 Farm 2 
Total number of calves recruited 66 88 
Calves that developed pyrexia 43 40 
Calves in treatment group 1 (NSAID) 21 20 
Calves in treatment group 2 (antimicrobial) 22 20 
Undifferentiated pyrexia prevalence (%) 65.2 45.5 
Calves excluded due to navel ill 2 6 
Calves excluded due to diarrhoea 8 4 
 166 
Of the 83/134 (61.9%) calves with respiratory disease related pyrexia, none developed acute signs of 167 
respiratory disease within 24 hours of pyrexia being detected. A total 58/83 (69.9%) calves received 168 
antimicrobials as part of the treatment protocol for the initial case of pyrexia detected (26 calves 169 
from Group 1 (NSAID) and 32 calves from Group 2 (antimicrobial)). Additional treatments (Group 1 170 
received additional antimicrobial and Group 2 received additional NSAID) were administered after 171 
72 hours in 42 (50.6%) cases due to continued pyrexia. No calves died while on the study although 172 
there was a 10% mortality rate amongst the calves excluded from the study (2/20 excluded calves 173 
died). 174 
 175 
Calves in treatment Group 1 (NSAID) were five times more likely (p=0.002) to require additional 176 
treatment (antimicrobial) to resolve pyrexia compared to Group 2 who received antimicrobials as 177 
their first line treatment (Table 3). However 25.7% of calves in Group 1 did recover following NSAID 178 
treatment alone. There was no significant difference in the number of calves that developed 179 
repeated pyrexia between the two treatment groups (p=0.73). The ANOVA indicated there was no 180 
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significant difference in the daily live weight gain of the calves between the treatment groups 181 
(p=0.632), with a mean daily live weight gain of 0.64kg/day (SE +/- 0.02). 182 
 183 
Table 3: The odds ratio and p-values associated with the successful resolution of a case of 184 
undifferentiated pyrexia. 185 
 186 
Variable Odds ratio (95% CI) p-value 
Sex 0.47 (0.11-2.05) 0.31 
Treatment group 5.09 (1.84-14.10) 0.002 
Farm 0.24 (0.065-0.88) 0.031 
Diarrhoea 0.42 (0.11-1.70) 0.22 
 187 
 188 
 189 
Results from the binary logistic regression model (Table 4) indicated that calves were less likely to 190 
require a second treatment if in Treatment Group 2 (antimicrobial) (p=0.003) and on Farm 2 191 
(p=0.050). There was no effect on the odds of requiring a second treatment of sex (p=0.363) or 192 
having diarrhoea (p=0.976). 193 
 194 
Table 4: The effect of different variables on the requirement for a second treatment 72 hours after 195 
the initial onset of pyrexia was detected. 196 
Variable Odds ratio (95% CI) p-value 
Sex 2.31 (0.38-14.0) 0.36 
Treatment group 0.16 (0.05-0.52) 0.003 
Farm 4.78 (0.99-22.93) 0.050 
Diarrhoea 1.03 (0.17-6.17) 0.98 
 197 
 198 
The Kaplan Meier survival analysis (Figure 2) for time to development of the first pyrexia 199 
experienced by pre-weaning calves produced a median age of 25 days (IQR 15-32 days). 200 
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 201 
Figure 2: Kaplan Meier survival analysis of the age (days) that respiratory disease related pyrexia 202 
developed in pre-weaning calves. 203 
 204 
For the post-weaning period until 6 months of age, one calf died for unknown reasons (from Group 205 
2) and two calves required additional treatment for calf pneumonia (of which one calf was from 206 
Group 1 and one was from Group 2). 207 
 208 
Discussion 209 
This randomised clinical trial investigated the efficacy of NSAID only treatment in comparison to 210 
antimicrobial therapy for undifferentiated pyrexia in calves, which was considered to be due to 211 
respiratory disease though a diagnosis of exclusion. The results indicate that using NSAIDs as the first 212 
line treatment resulted in calves being  five times more likely (p=0.002) to require an additional 213 
treatment (antimicrobials) to resolve pyrexia compared to the use of antibiotics as the first line of 214 
treatment. However, the initial treatment group had no significant effect on the daily live weight 215 
gain or the prevalence of recurrent pyrexia episodes experienced by the calves. The early use of 216 
antimicrobials led to resolution of 64.7% of the initial cases of pneumonia, compared to a 25.7% 217 
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success rate using a NSAID treatment alone (Table 2). None-the-less, this study demonstrates the 218 
potential for reducing antimicrobial usage with NSAID initial treatment, as the delay in receiving the 219 
additional treatment of antimicrobials did not appear to have long term detrimental effects on calf 220 
health up to 6 months of age.  221 
 222 
There is an internationally recognised need to reduce current usage of antimicrobials in animals 223 
farmed for food production, especially prophylactic and metaphylactic use which has been common 224 
practice on calf rearing units with pneumonia epidemics (Ives & Richeson, 2015). Multi-drug 225 
resistant bacteria are already present within the population of pneumonia pathogens, with 226 
Pasteurella multocida demonstrating concurrent resistance to three antibiotics in 2.1% of isolates 227 
(Jamali and others, 2014). The World Health Organisation (WHO) has recommended restricting the 228 
use of some antimicrobial classes in food-producing animals, along with tighter regulations in some 229 
European countries, highlighting the need for new methods to control antimicrobial usage in order 230 
to maintain their efficacy and availability (WHO, 2014). Establishing treatment protocols that can 231 
improve the rationale and reduce the use of antimicrobials is an important aspect of a veterinarian’s 232 
role in the food-producing animal sector. Traditionally, poor observer sensitivity to the clinical signs 233 
of pneumonia has resulted in administration of treatments to animals whose initial acute 234 
pneumonia has progressed to a chronic suppurative form (Barrett, 2000), resulting in a poor 235 
response to treatment, chronic weight loss and increased mortality rates (Breeze, 1985).  236 
 237 
Whether the initial course of treatment following detection of pneumonia is NSAID or antimicrobial 238 
therapy alone, or the two in combination, early detection and resolution of calf pneumonia may 239 
reduce the amount of antimicrobial usage due to limitation of the severity of the disease, and 240 
reduction in spread of pathogens to other animals in the shared air space and therefore reduced 241 
development of new cases. The use of NSAIDs may be an important strategy for clinicians providing 242 
treatment and safeguarding welfare while withholding antimicrobial treatments. There is a strong 243 
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rationale for NSAID use in cases of pneumonia, primarily to reduce excessive inflammation 244 
associated with cell mediated immunity, cytokines and endotoxin release (Panciera & Confer, 2010). 245 
Despite the fact that many initial cases of pneumonia are primarily of viral aetiology (Tuncer & 246 
Yesilbag, 2015) and are only complicated by later/secondary bacterial infection, NSAIDs and 247 
antibiotics in combination remain necessary for most cases of calf pneumonia as demonstrated in 248 
this sample. 249 
 250 
The protocol for early pyrexia detection though the use of FeverTags in this study enabled treatment 251 
to be administered much earlier in the disease course compared to what is achievable on most 252 
farms, leading to a reduction in the transmission of pathogens to other calves in the same air space, 253 
and a reduction in the total amount of antimicrobial administered to the calves. This resulted in a 254 
total of only 83/154 calves requiring any form treatment, with only 58/83 of the total treatments 255 
given for the initial pyrexia detected being antimicrobial, which is a 30.1% reduction in antimicrobial 256 
usage compared to a prophylactic antibiotic treatment strategy, and a 62.3% reduction when 257 
compared to a metaphylactic treatment strategy. This suggests the use of NSAIDs as a first line 258 
treatment for early onset calf pneumonia as indicated by pyrexia may be a suitable treatment 259 
protocol provided sufficient attention is given to continuous monitoring and suitable consideration 260 
of the need for an additional treatment with antimicrobials if the pyrexia does not resolve. However 261 
definitive conclusions on the efficacy of NSAID treatment is difficult to establish due to it being 262 
deemed ethically inappropriate to withhold treatment in a negative control group in this study, 263 
although further work could explore the effect of NSAID only treatment for early on-set pneumonia 264 
through the use of both positive and negative control groups. 265 
 266 
One possible reason for the apparent lack of efficacy of NSAID only treatment may have been that 267 
the pyrexia threshold used in this study (39.7oc) was too high. Other sources have indicated that the 268 
upper range for the normal body temperature of cattle is 39.2oC (Divers & Peek, 2008), with a rectal 269 
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temperature between 38.9 – 39.4 oC being given an abnormal classification (Lago and others, 2006). 270 
This suggests that lowering the temperature threshold for activation of the temperature monitors 271 
may be more appropriate. This may lead to the introduction of therapy before significant lung 272 
damage has occurred; in this study it would appear that the initiating agents had already caused 273 
damage to the respiratory clearance mechanisms and lung parenchyma when treatment was 274 
initiated, so facilitating secondary bacterial infection in the compromised lung (Taylor and others, 275 
2010) with the resultant need for antimicrobials. This pathogenesis is supported by the high success 276 
rate of the antimicrobial therapy in this study, which supports the theory that it is the presence of 277 
bacterial pathogens that has caused the pathology in the respiratory tract, resulting in an increased 278 
requirement of Group 1 (NSAID) calves (39%, p<0.01) to be treated with antimicrobial due to lack of 279 
resolution of pyrexia.  Another possible reason for the reduced efficacy of the NSAID treatment is 280 
the anti-pyretic nature of this drug type. Respiratory viruses have an optimal body temperature 281 
range for their in vivo survival, and the development of pyrexia may actually be beneficial as part of 282 
the immune defence system (Apley, 2006). This could mean that antipyretics are not an optimal 283 
treatment during per-acute viral pneumonia infection. Further work comparing NSAID treatment 284 
with a negative control group would further elucidate this question. 285 
 286 
The overall period prevalence of pneumonia detected by this study was 61.9% which is higher than 287 
47% suggested by ADAS (2015), although this study did have a lower population number of calves 288 
who were selected due their high risk housing management. Both farms had calves housed in large 289 
shared air spaces, without the minimum recommended number of four air changes per hour being 290 
met (Bates & Anderson, 1979). This can result in raised airborne bacterial levels, which also occurs 291 
with raised stocking densities (Lago and others, 2006). Although the majority of airborne bacteria 292 
are non-pathogenic, they can provide an additional burden to the respiratory tract defences 293 
(Wathes, et al., 1983). The use of group pens with no solid barriers has also previously been 294 
demonstrated to be a risk factor for calf pneumonia due to reduced exchange of airborne pathogens 295 
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between pens as well as preventing direct nose to nose contact (Lago and others, 2006). All of these 296 
risk factors were present on the study farms, which may account for the high incidence of 297 
pneumonia detected. The median age at which pneumonia was detected in this study was 25 days, 298 
which is in agreement with Elliott and others (2014) that indicated 53.7% of pneumonia occurred in 299 
calves aged between two weeks and two months. This confirms that close monitoring of calves 300 
during this time period is important. 301 
 302 
The eight calves excluded for developing navel ill all developed pyrexia that was identified by the 303 
FeverTags, but only two of the 12 calves excluded for diarrhoea were detected as pyrexic. The 304 
clinical exam and diagnosis was carried out by a trained farmer, although no confirmatory diagnostic 305 
tests were carried out. This indicates that the temperature monitors can be beneficial for detecting 306 
any calf disease that produces pyrexia such as navel ill, with activation of the temperature monitors 307 
triggering a general clinical exam of a calf, therefore increasing detection rates of disease. During 308 
this study, no cases of otitis or other ear infections were observed to be caused by the placement of 309 
the FeverTags, with only some mild inflammation noted around the FeverTag placement in the pinna 310 
which would be expected during normal identification ear tag placement. 311 
 312 
A significant advantage of the temperature monitors in the study was the constant real-time 313 
monitoring of the calves’ health status, aiding in early detection and therefore prompt initiation of 314 
treatment. In many conventional systems, continued monitoring of sick calves after treatment is 315 
challenging, leading to a further delay in the provision of secondary or repeat treatments for calves 316 
that continue to experience pyrexia or progression of clinical symptoms. A total of 42 calves 317 
experienced continued pyrexia following initial treatment, with a further 23 calves having a repeat 318 
episode of pyrexia, indicating the high requirement for continued monitoring of animals previously 319 
identified as sick. 320 
 321 
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A major limitation of this study was the lack of definitive diagnosis and pathogen identification from 322 
pyrexic calves, as this would have allowed more robust conclusions to be drawn regarding the 323 
nature of the primary respiratory disease pathogens. Pneumonia in pre-weaned calves can have 324 
both viral and bacterial aetiologies, with bacterial pathogens primarily occurring following stressful 325 
procedures such as transport, castration or disbudding (Gorden & Plummer, 2010). In this study, the 326 
detection of pneumonia was primarily by development of pyrexia, with the exclusion of other causes 327 
through a thorough clinical examination since early cases of pneumonia would be unlikely to exhibit 328 
typical clinical signs such as  raised respiratory rate, altered respiratory character, observed 329 
anorexia, nasal discharge, ocular discharge, coughing, and depression  (Apley, 2006). This is 330 
supported by Apley (2006) who concluded that in order to initiate early treatment, a presumptive 331 
diagnosis of pneumonia would often have to occur on the basis of depression and an 332 
undifferentiated fever. Combining the use of TempVerified FeverTags with other calf monitoring 333 
tools such as the scoring system described by Lago and others, (2006) whereby individual animals 334 
are examined and given a clinical score based on temperature, nasal discharge, cough, ocular 335 
discharge and ear position may provide the most sensitive and specific method for the early 336 
detection and therefore treatment of calf pneumonia. 337 
 338 
 339 
Conclusion 340 
Calf pneumonia is a costly disease affecting animals both in the dairy and beef industry, with long 341 
lasting consequences on growth and productivity. The initiation of early treatment is important for 342 
reduction in lung pathology, reducing risk of secondary infection and stopping progression of clinical 343 
signs. The targeted use of NSAIDs and antimicrobials in pyrexic calves and continued monitoring 344 
post-treatment provides a time-efficient and easy to use method to help stock people ensure high 345 
standards of calf welfare and health are maintained. Although prevention of pneumonia will be the 346 
target for calf producers, the use of real-time temperature monitoring systems along with targeted 347 
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therapy does allow for very early identification and initiation of pneumonia treatment, along with a 348 
30.1% reduction in antimicrobial usage in this study. 349 
 350 
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